Rebalix
Vanguard · sheet of 5 September 2026
Vanguard · sheet of 5 September 2026ETF sheet · official issuer and register data
Vanguard FTSE All-World High Dividend Yield UCITS ETF (USD) Accumulating
VHYA · IE00BK5BR626 · USD · domicile Ireland
Equity · Global · DividendSFDR art. 6 (inferred)
Index tracked: FTSE All-World High Dividend Yield Index
- TER
- 0.29%+ trans. 0.03%
- Fund size
- 12.2 bn EUR
- Tracking difference
- +0.11%3-year avg
- 🇮🇹 tax rate
- 26.00%equity
- Replication
- Physical (sampled)
- Income
- Accumulating
Launch 24 Sept 2019 · costs from the KID as of 2 Sept 2026 · 2,909 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE All-World High Dividend Yield Index (the “Index”). The Index is comprised of large and mid-sized company stocks, excluding real estate trusts, in developed and emerging markets that pay dividends that are generally higher than average. The Fund attempts to: 1. Track the performance of the Index by investing through physical acquisition in a representative sample of Index constituent…
Performance since series start (in euro) — base 100
31 Oct 2019 → 31 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +31.3% |
| 3 years | +57.3% |
| 5 years | +80.7% |
| 10 years | series too young |
| Since series start | +101.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 9.16% | 9.87% | 11.05% |
| Max drawdown | −8.05% | −11.40% | −21.10% |
| Sharpe | 2.42 | 1.55 | 0.84 |
| Sortino | 3.92 | 2.16 | 1.17 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VHYA · IE00BK5BR6261
RebalixVHYA · IE00BK5BR626 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +26.40% | +26.33% | +0.07% |
| 2024 | +9.39% | +9.24% | +0.15% |
| 2023 | +11.51% | +11.39% | +0.12% |
| 2022 | −5.73% | −5.72% | −0.02% |
| 2020 | −0.26% | −0.32% | +0.06% |
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 2,909 securities · top-10 weight = 11.4%
| Top holdings | Weight |
|---|---|
| 2.2% | |
| 1.5% | |
| 1.4% | |
| 1.1% | |
| 1.0% | |
| 0.9% | |
| 0.9% | |
| 0.8% | |
| 0.8% | |
| 0.8% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
VHYA · Borsa Italiana (ETFplus)
VGWE · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
+ 17 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BK5BR626
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BK5BR626
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · VHYA · IE00BK5BR6262